Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025.  It works with innovator pharma and biotech companies across USA, EU & Japan, accelerating the discovery, development and manufacture of complex small molecules. Over the past two decades, Sai Life Sciences has consistently delivered on a diverse set of NCE development programs for its customers with a track record of bringing value based on quality, pricing and responsiveness. Today, as one of India’s fastest growing CDMO companies, Sai Life Sciences works with the leading large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is backed by committed long-term investors, TPG Capital and HBM Healthcare Investments.

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPhI Japan 2020

Osaka, Japan

14 - 16 April 2021

Book a meeting
View Our Exhibitor Profile

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

31 August - 2 September 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Dapsone

Sai Life Sciences

Request Info

Doxercalciferol

Sai Life Sciences

Request Info

Enzalutamide

Sai Life Sciences

Request Info

Epoprostenol

Sai Life Sciences

Request Info

Our Resources

Categories affiliated with Sai Life Sciences